M.K. Palmer

2.1k total citations
35 papers, 1.6k citations indexed

About

M.K. Palmer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, M.K. Palmer has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nephrology. Recurrent topics in M.K. Palmer's work include Lipoproteins and Cardiovascular Health (8 papers), Parathyroid Disorders and Treatments (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). M.K. Palmer is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Parathyroid Disorders and Treatments (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). M.K. Palmer collaborates with scholars based in Sweden, United Kingdom and United States. M.K. Palmer's co-authors include Sver­ker Ljunghall, E. Schvarcz, Jan Åman, Göran Åkerström, Christian Berne, Michael Horowitz, Mats Stridsberg, R. Bergström, Sören Jakobsson and Peter Arner and has published in prestigious journals such as Gastroenterology, Diabetologia and Atherosclerosis.

In The Last Decade

M.K. Palmer

34 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M.K. Palmer 473 453 439 388 291 35 1.6k
Erman Çakal 451 1.0× 179 0.4× 191 0.4× 1.0k 2.6× 47 0.2× 196 2.1k
Henry N. Hulter 179 0.4× 622 1.4× 1.5k 3.4× 216 0.6× 77 0.3× 67 2.4k
Norbert Runkel 1.1k 2.4× 255 0.6× 70 0.2× 176 0.5× 168 0.6× 67 1.9k
Bruno Salerni 761 1.6× 199 0.4× 102 0.2× 184 0.5× 370 1.3× 69 1.4k
Johanna C. Andersson‐Assarsson 1.6k 3.3× 868 1.9× 59 0.1× 498 1.3× 691 2.4× 66 2.9k
Jacek Dadan 607 1.3× 463 1.0× 64 0.1× 260 0.7× 58 0.2× 124 1.5k
Sema Akalın 277 0.6× 189 0.4× 71 0.2× 488 1.3× 85 0.3× 54 1.4k
J N Baxter 1.8k 3.8× 303 0.7× 85 0.2× 91 0.2× 175 0.6× 73 2.7k
Séverine Ledoux 1.3k 2.8× 1.0k 2.2× 52 0.1× 302 0.8× 174 0.6× 84 2.6k
Paolo Bernante 1.8k 3.8× 458 1.0× 140 0.3× 1.3k 3.4× 47 0.2× 69 2.5k

Countries citing papers authored by M.K. Palmer

Since Specialization
Citations

This map shows the geographic impact of M.K. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.K. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.K. Palmer more than expected).

Fields of papers citing papers by M.K. Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.K. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.K. Palmer. The network helps show where M.K. Palmer may publish in the future.

Co-authorship network of co-authors of M.K. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of M.K. Palmer. A scholar is included among the top collaborators of M.K. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.K. Palmer. M.K. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlson, B.W., Philip J. Barter, M.K. Palmer, Pia Lundman, & Stephen J. Nicholls. (2012). Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: Results from VOYAGER. Nutrition Metabolism and Cardiovascular Diseases. 22(9). 697–703. 13 indexed citations
2.
Peters, Sanne A. E., Hester M. den Ruijter, M.K. Palmer, et al.. (2011). Manual or semi‐automated edge detection of the maximal far wall common carotid intima–media thickness: a direct comparison. Journal of Internal Medicine. 271(3). 247–256. 23 indexed citations
3.
Peters, Sanne A. E., Lars Lind, M.K. Palmer, et al.. (2011). Increased age, high body mass index and low HDL‐C levels are related to an echolucent carotid intima–media: the METEOR study. Journal of Internal Medicine. 272(3). 257–266. 45 indexed citations
4.
Peters, Sanne A. E., M.K. Palmer, Diederick E. Grobbee, et al.. (2010). C‐reactive protein lowering with rosuvastatin in the METEOR study. Journal of Internal Medicine. 268(2). 155–161. 28 indexed citations
5.
Hoffstedt, Johan, Peter Arner, Hans Wahrenberg, et al.. (2010). Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia. 53(12). 2496–2503. 180 indexed citations
6.
Bots, Michiel L., M.K. Palmer, Soner Doğan, et al.. (2009). Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. Journal of Internal Medicine. 265(6). 698–707. 34 indexed citations
7.
Agardh, C.–D., K. F. Lynch, M.K. Palmer, K. Link, & Åke Lernmark. (2009). GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes. Diabetologia. 52(7). 1363–1368. 71 indexed citations
8.
Shah, Naman K., et al.. (2001). Management strategies for rising pharmaceutical expenditures. 26(3). 140–148. 1 indexed citations
9.
Palmer, M.K., et al.. (2001). Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatrica. 90(10). 1127–1130. 5 indexed citations
10.
Esbjörner, Elisabeth, et al.. (2001). Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatrica. 90(10). 1127–1130. 13 indexed citations
11.
Palmer, M.K., et al.. (1998). Prevalence of urinary tract symptoms in long-standing type 1 diabetes mellitus.. PubMed. 24(4). 351–4. 18 indexed citations
12.
Schvarcz, E., M.K. Palmer, Jan Åman, et al.. (1997). Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology. 113(1). 60–66. 331 indexed citations
13.
Schvarcz, E., et al.. (1996). Increased Prevalence of Upper Gastrointestinal Symptoms in Long-term Type 1 Diabetes Mellitus. Diabetic Medicine. 13(5). 478–481. 97 indexed citations
14.
Schvarcz, E., M.K. Palmer, Jan Åman, Björn Lindkvist, & Karl-Wilhelm Beckman. (1993). Hypoglycaemia Increases the Gastric Emptying Rate in Patients with Type 1 Diabetes Mellitus. Diabetic Medicine. 10(7). 660–663. 103 indexed citations
15.
Lind, Lars, et al.. (1991). Cardiovascular risk factors in primary hyperparathyroidism: a 15‐year follow‐up of operated and unoperated cases. Journal of Internal Medicine. 230(1). 29–35. 44 indexed citations
16.
Lind, Lars, Andreas Hvarfner, M.K. Palmer, et al.. (1991). Hypertension in primary hyperparathyroidism in relation to histopathology.. PubMed. 157(8). 457–9. 18 indexed citations
17.
Palmer, M.K., Sören Jakobsson, Göran Åkerström, & Sver­ker Ljunghall. (1988). Prevalence of hypercalcaemia in a health survey: a 14‐year follow‐up study of serum calcium values. European Journal of Clinical Investigation. 18(1). 39–46. 137 indexed citations
18.
Palmer, M.K., et al.. (1987). Serum calcium in bronchial carcinoma: a population-based study.. PubMed. 70(1). 8–13. 2 indexed citations
19.
Muhr, Carin, Sver­ker Ljunghall, Göran Åkerström, et al.. (1984). SCREENING FOR MULTIPLE ENDOCRINE NEOPLASIA SYNDROME (TYPE 1) IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. Clinical Endocrinology. 20(2). 153–162. 15 indexed citations
20.
Phillips, G. D., et al.. (1974). A STUDY OF THE UTERO-OVARIAN CIRCULATION IN SHEEP WITH REFERENCE TO LOCAL TRANSFER BETWEEN VENOUS AND ARTERIAL BLOOD. Reproduction. 36(2). 319–331. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026